|
Volumn 412, Issue 6845, 2001, Pages 452-455
|
Antibacterial agents based on the cyclic D, L-α-peptide architecture
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODIES;
BACTERIA;
BIOLOGICAL MEMBRANES;
CELLS;
DISEASES;
MECHANICAL PERMEABILITY;
PEPTIDES;
DRUG DOSAGE;
ANTIINFECTIVE AGENT;
CYCLIC ALPHA PEPTIDE DERIVATIVE;
CYCLOPEPTIDE;
POLYPEPTIDE ANTIBIOTIC AGENT;
UNCLASSIFIED DRUG;
BACTERIAL DISEASE;
DRUG DEVELOPMENT;
ARTICLE;
BACTERIAL INFECTION;
CELL DEATH;
DRUG STRUCTURE;
GRAM NEGATIVE BACTERIUM;
GRAM POSITIVE BACTERIUM;
MEMBRANE PERMEABILITY;
MEMBRANE POTENTIAL;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MOLECULAR WEIGHT;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
ANIMALS;
ANTI-BACTERIAL AGENTS;
CELL MEMBRANE;
CELL MEMBRANE PERMEABILITY;
DRUG DESIGN;
GRAM-NEGATIVE BACTERIA;
GRAM-POSITIVE BACTERIA;
MALE;
MEMBRANE POTENTIALS;
MICE;
MICE, INBRED BALB C;
MICROBIAL SENSITIVITY TESTS;
PEPTIDES, CYCLIC;
PILOT PROJECTS;
STAPHYLOCOCCAL INFECTIONS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0035954729
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/35086601 Document Type: Article |
Times cited : (878)
|
References (22)
|